Skip to main content
Clinical Trials/NCT05490069
NCT05490069CompletedNot Applicable

The Effect of Instant Message Intervention for Psychological Well-being Among Stroke Survivors

The University of Hong Kong7 sites in 1 country40 target enrollmentStarted: October 4, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
40
Locations
7
Primary Endpoint
Depressive symptoms (Patient Health Questionnaire-9 [PHQ-9])

Study Overview

Brief Summary

The proposed pilot trial aims to evaluate the feasibility of iCBT based EMI, which is a real-time, real-world, personalised and cost-effective approach, for stroke survivors' psychological well-being.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diagnosis of stroke (ICD-10 codes: I60-I69)
  • •Able to read and communicate in Chinese (Cantonese or Putonghua)
  • •Able to use text messaging function on mobile phones
  • •MoCA 5-minute Protocol (cognitive screen) ≥14 (Equivalence to MMSE ≥ 21)
  • •Discharged home from hospital within preceding 6 months
  • •PHQ-9 (depressive symptom) score range from 5 to 19 (cf. mild: 5-9, moderate: 10-14, moderately severe: 15-19 and severe: 20-27)

Exclusion Criteria

  • •Currently receiving active stroke care in acute or post-acute inpatient settings
  • •Has diagnosis of psychiatric disease or is currently taking psychotropic drug
  • •PHQ-9 ≥ 20 (i.e., severe depressive symptom)
  • •Currently participating in any type of psychological intervention (e.g., CBT)

Arms & Interventions

Intervention group

Experimental

Receive iCBT based EMI with message content, delivery frequency and timing personalised to participants' preferences.

Intervention: iCBT-based EMI (Other)

Control group

No Intervention

Receive general mental health information through instant message.

Outcomes

Primary Outcomes

Depressive symptoms (Patient Health Questionnaire-9 [PHQ-9])

Time Frame: 24-week

A 9-item scale with score ranging from 0 to 27, higher scores indicate higher severity of depressive symptom

Secondary Outcomes

  • Anxiety symptoms (Generalized Anxiety Disorder-7 [GAD-7])(24-week)
  • Stress level (Perceived Stress Scale [PSS-4])(24-week)
  • Spiritual well-being (Sub-scale of Spirituality Scale for Chinese Elders [SSCE])(24-week)
  • Loneliness (UCLA Loneliness Scale [ULS-8])(24-week)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (7)

Loading locations...

Similar Trials